Neonatal sleep development and early learning in infants with prenatal opioid exposure

Nicole A Heller1, Hira Shrestha2, Deborah G Morrison3

  • 1Department of Psychology, Siena College, Loudonville, NY, United States.

Insights

Poor neonatal sleep in at-risk infants is both a result of perinatal risks and a predictor of later attention and cognitive issues. Early interventions addressing sleep are crucial for developmental outcomes.

Area of Science:

  • Developmental Psychology
  • Neuroscience
  • Pediatrics

Background:

  • The cumulative risk model suggests multiple factors negatively impact child development.
  • These factors include prenatal exposures, prematurity, socioeconomic status, parenting, and sleep.
  • Poor neonatal sleep is a significant, yet often overlooked, factor in this model.

Purpose of the Study:

  • To examine the interplay between sleep and cognition in at-risk infants within the cumulative risk framework.
  • To understand poor neonatal sleep as both an outcome and a predictor of developmental challenges.
  • To identify implications and interventions for at-risk maternal-infant dyads.

Main Methods:

  • Analysis of at-risk infant and maternal-infant dyad samples.
  • Examination of neonatal sleep patterns in relation to other known risk factors.
  • Review of existing literature on sleep, cognition, and cumulative risk.

Main Results:

  • Poor neonatal sleep is identified as both a consequence of perinatal adversity and a risk factor for cognitive development.
  • Specific outcomes associated with poor sleep and cognition in infancy are detailed.
  • The relationship between sleep disturbances and other cumulative risks is highlighted.

Conclusions:

  • Neonatal sleep is a critical component of the cumulative risk model impacting infant development.
  • Interventions targeting sleep in at-risk infants may mitigate negative cognitive and attentional outcomes.
  • Further research and clinical attention to infant sleep are warranted.

Related Concept Videos

Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
276
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.3K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.1K